FAKTOR YANG MEMPENGARUHI KEGAGALAN PROSEDUR PLASMAFERESIS PADA PENDONOR PLASMA KONVALESEN DI UTD PMI KOTA YOGYAKARTA

Francisca Romana Sri Supadmi, Nur’aini Purnamaningsih, Diah Nurpratami, Devita Akmarizanah,Dani Irawan

Abstract


Penggunaan Plasma Covid-19 pertama kali dilakukan untuk pengobatan pasien COVID-19 di China. Meskipun belum ada data pasti, namun berdasarkan peningkatan kasus sembuh, menumbuhkan harapan baru untuk didapatkannya antibodi yang terdapat di dalam plasma konvalesen. Tujuan penelitian untuk mengetahui faktor-faktor yang mempengaruhi kegagalan prosedur plasmaferesis pada pendonor plasma konvalesen. Penelitian ini merupakan penelitian deskriptif frekuentif. Populasi penelitian semua pendonor plasma konvalesen selama dilakukan penelitian dan jumlah sampel pada penelitian ini 38 sampel dengan teknik pengambilan accidental sampling. Pengumpulan data dengan menggunakan formulir pencatatan yang dirancang sesuai tujuan penelitian dan data yang terkumpul dianalisis secara deskriptif frekuentif. Hasil penelitian, dari 38 sampel terdapat 50% calon pendonor dapat diambil plasma konvalesen, namun 50% mengalami kegagalan. Faktor penyebab kegagalan mayoritas disebabkan oleh karena titer antibody yang kurang dari 80.

Keywords


Plasmaferesis; Plasma Konvalesen; Pendonor Darah; Covid-19

Full Text:

PDF

References


C. Sohrabi et al., “World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19),†International Journal of Surgery. 2020. doi:10.1016/j.ijsu.2020.02.034.

C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,†The Lancet, 2020, doi: 10.1016/S0140-6736(20)30183-5.

W. H. Huang et al., “2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China,†Journal of Microbiology, Immunology and Infection, 2020, doi:

1016/j.jmii.2020.02.009.

M. Zhou, X. Zhang, and J. Qu, “Coronavirus disease 2019 (COVID-19): a clinical update,†Frontiers of medicine. 2020. doi: 10.1007/s11684-020-0767-8.

World Health Organization (WHO), “WHO Coronavirus Disease (COVID-19) Dashboard.†2020.

S. P. Covid-19, “No Title.†2020.

F. Zeng, X. Chen, and G. Deng, “Convalescent plasma for patients with COVID-19,†Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 23, p. 12528, 2020, doi: 10.1073/pnas.2006961117.

H. S. H. Houng, D. Norwood, G. V. Ludwig, W. Sun, M. Lin, and D. W. Vaughn, “Development and evaluation of an efficient 3′-noncoding region based SARS coronavirus (SARS-CoV) RT-PCR assay for detection of SARS-CoV infections,†Journal of Virological Methods, 2004, doi: 10.1016/j.jviromet.2004.04.008.

C. Shen et al., “Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma,†JAMA - Journal of the American Medical Association, 2020, doi: 10.1001/jama.2020.4783.

M. Shen et al., “Recent advances and perspectives of nucleic acid detection for coronavirus,†Journal of Pharmaceutical Analysis. 2020. doi: 10.1016/j.jpha.2020.02.010.

Menteri Kesehatan, Peraturan Menteri Kesehatan RI No 91 Tahun 2015 tentang Standar Pelayanan Transfusi Darah. Jakarta, 2015. Accessed: Jan. 01, 2022. [Online]. Available: http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No._91_ttg_Standar_Transfusi_Pelayanan_Darah_.pdf

M. S. Maulana, “EFEKTIVITAS EFIKASI PEMBERIAN TERAPI KONVALESEN PLASMA PADA PASIEN COVID-19 : EVIDENCE BASED CASE REPORT,†Jurnal Kedokteran dan Kesehatan : Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya, vol.7, no. 3, pp. 7–14, Oct. 2020, doi: 10.32539/jkk.v7i3.12297.

M. Ye et al., “Treatment with convalescent plasma for COVID-19 patients in Wuhan, China,†Journal of Medical Virology, 2020, doi: 10.1002/jmv.25882.

C. Shen et al., “Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma,†JAMA - Journal of the American Medical Association, vol. 323, no. 16, pp. 1582–1589, 2020, doi: 10.1001/jama.2020.4783.

Y. Cheng et al., “Use of convalescent plasma therapy in SARS patients in Hong Kong,†no. March 2003, pp. 44–46, 2005, doi: 10.1007/s10096-004-1271-9.

F. R. S. Supadmi, T. D. E. Susilo, and N. Mumpuni, “Literatur Review: Terapi Plasma Konvalesen bagi Pasien Covid-19,†Jurnal Medica Arteriana, vol. 3, no. 1, pp. 53–61, 2021, Accessed: Dec. 20, 2021. [Online]. Available: https://jurnal.unimus.ac.id/index.php/MedArt/article/view/7586

J. F. W. Chan et al., “Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan,†Emerging Microbes and Infections, vol. 9, no. 1, pp. 221–236, 2020, doi: 10.1080/22221751.2020.1719902.

R. A. Khailany, M. Safdar, and M. Ozaslan, “Genomic characterization of a novel SARS-CoV2,†Gene Reports, 2020, doi: 10.1016/j.genrep.2020.100682.

R. S. E. Gantini et al., PROTOKOL PENYIAPAN PLASMA KONVALESEN UNTUK TERAPI COVID-19 DI UNIT DONOR DARAH PALANG MERAH INDONESIA, 1st ed. Jakarta: Unit Donor Darah Pusat Palang Merah Indonesia, 2020.


Refbacks

  • There are currently no refbacks.




Prosiding Seminar Nasional

Universitas Respati Yogyakarta

Alamat : JL. Laksda Adisucipto KM 6,3 Depok Sleman Yogyakarta - Indonesia
Tel : 0274-488781
Fax : 0274-489780
Email : wahyurm@respati.ac.id


 
View My Stats
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.